资讯
10 小时
Clinical Trials Arena on MSNMSD and Daiichi announce first subject dosing in prostate cancer trialMSD and Daiichi Sankyo have announced first subject dosing in the randomised IDeate-Prostate01 Phase III trial of ifinatamab ...
Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial ...
The White House says President Donald Trump will decide within the next two weeks whether to strike Iran. It says Trump still ...
Israel’s defense minister threatened Iran’s supreme leader after Iranian missiles damaged a hospital in southern Israel and ...
The Israeli military said Thursday that Iran used a missile with multiple warheads in its attack, posing a new challenge to ...
Israel’s defense minister has overtly threatened Iran’s supreme leader after the latest missile barrage from Iran damaged a ...
A human rights group says Israeli strikes on Iran have killed at least 639 people and wounded 1,329 others. The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果